Welcome to Paid Research Studies




  • Conditions:   ALK Gene Mutation;   BRAF Gene Mutation;   EGFR Gene Mutation;   Head and Neck Squamous Cell Carcinoma;   Metastatic Head and Neck Carcinoma;   Recurrent Head and Neck Carcinoma;   Recurrent Non-Small Cell Lung Carcinoma;   ROS1 Gene Mutation;   Stage III Non-Small Cell Lung Cancer;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IV Non-Small Cell Lung Cancer
    Interventions:   Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab;   Biological: Recombinant EphB4-HSA Fusion Protein
    Sponsors:   University of Southern California;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Recurrent Bladder Carcinoma;   Bladder Cancer Stage 0;   Bladder Cancer Stage I
    Interventions:   Other: Pharmacokinetic Study;   Biological: Recombinant EphB4-HSA Fusion Protein
    Sponsors:   University of Southern California;   National Cancer Institute (NCI)
    Not yet recruiting

  • Conditions:   Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome;   Blasts 5 Percent or More of Bone Marrow Nucleated Cells;   Myelodysplastic/Myeloproliferative Neoplasm;   Philadelphia Chromosome Positive;   Recurrent Acute Lymphoblastic Leukemia;   Recurrent Adult Acute Myeloid Leukemia;   Refractory Acute Lymphoblastic Leukemia;   Refractory Acute Myeloid Leukemia;   Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Secondary Acute Myeloid Leukemia;   T Acute Lymphoblastic Leukemia
    Interventions:   Drug: Cytarabine;   Other: Laboratory Biomarker Analysis;   Biological: Recombinant EphB4-HSA Fusion Protein;   Drug: Vincristine Liposomal
    Sponsors:   University of Southern California;   National Cancer Institute (NCI);   Vasgene Therapeutics, Inc;   Whittier Foundation
    Recruiting

  • Conditions:   Infiltrating Bladder Urothelial Carcinoma;   Recurrent Bladder Carcinoma;   Stage I Prostate Cancer;   Stage I Renal Cell Cancer;   Stage II Bladder Urothelial Carcinoma;   Stage II Renal Cell Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage III Renal Cell Cancer
    Interventions:   Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis;   Procedure: Radical Cystectomy;   Biological: Recombinant EphB4-HSA Fusion Protein;   Procedure: Therapeutic Conventional Surgery
    Sponsors:   University of Southern California;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome;   Chronic Myelomonocytic Leukemia;   Previously Treated Myelodysplastic Syndrome;   Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes;   Recurrent Adult Acute Myeloid Leukemia
    Interventions:   Drug: Azacitidine;   Drug: Decitabine;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Biological: Recombinant EphB4-HSA Fusion Protein
    Sponsors:   University of Southern California;   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Stage IV Bladder Urothelial Carcinoma
    Interventions:   Procedure: Computed Tomography;   Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab;   Procedure: Positron Emission Tomography;   Biological: Recombinant EphB4-HSA Fusion Protein
    Sponsors:   University of Southern California;   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Unspecified Adult Solid Tumor, Protocol Specific
    Interventions:   Other: laboratory biomarker analysis;   Other: pharmacological study;   Biological: recombinant albumin fusion protein sEphB4-HSA
    Sponsors:   University of Southern California;   National Cancer Institute (NCI);   Vasgene Therapeutics, Inc;   The V Foundation for Cancer Research
    Recruiting

  • Conditions:   Head and Neck Squamous Cell Carcinoma;   Metastatic Pancreatic Adenocarcinoma;   Non-Resectable Cholangiocarcinoma;   Pancreatic Adenocarcinoma;   Recurrent Gallbladder Carcinoma;   Recurrent Non-Small Cell Lung Carcinoma;   Stage III Pancreatic Cancer;   Stage IIIA Gallbladder Cancer;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Gallbladder Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IV Gallbladder Cancer;   Stage IV Non-Small Cell Lung Cancer;   Stage IV Pancreatic Cancer;   Unresectable Gallbladder Carcinoma;   Unresectable Pancreatic Cancer
    Interventions:   Drug: Cisplatin;   Drug: Docetaxel;   Drug: Gemcitabine Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel Albumin-Stabilized Nanoparticle Formulation;   Other: Pharmacological Study;   Biological: Recombinant EphB4-HSA Fusion Protein
    Sponsors:   University of Southern California;   National Cancer Institute (NCI);   Vasgene Therapeutics, Inc
    Recruiting

  • Condition:   Skin Kaposi Sarcoma
    Interventions:   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Behavioral: Quality-of-Life Assessment;   Biological: Recombinant EphB4-HSA Fusion Protein
    Sponsors:   AIDS Malignancy Consortium;   National Cancer Institute (NCI);   Vasgene Therapeutics, Inc;   The EMMES Corporation;   University of Arkansas
    Recruiting

  • Conditions:   Chronic Ischemic Left Ventricular Dysfunction;   Myocardial Infarction
    Interventions:   Drug: Autologous hMSCs;   Drug: Autologous Human C-Kit CSCs II;   Drug: Placebo;   Device: Biosense Webster MyoStar NOGA Injection Catheter System
    Sponsor:   Joshua M Hare
    Not yet recruiting

  • Conditions:   Monoclonal Gammopathy;   Smoldering Myeloma;   Myeloma
    Intervention:   Biological: DKK1
    Sponsor:   Case Comprehensive Cancer Center
    Not yet recruiting

  • Conditions:   CMV Infection;   Cytomegalovirus Infections;   CMV Viremia;   Opportunistic Infections
    Intervention:   Biological: CMV-specific T-cells
    Sponsors:   University of Wisconsin, Madison;   University of Wisconsin Program for Advanced Cell Therapy (PACT);   University of Wisconsin Carbone Cancer Center (UWCCC);   University of Wisconsin School of Medicine and Public Health (UWSMPH);   UW Health
    Not yet recruiting

  • Condition:   Hip Fracture
    Interventions:   Drug: PLX-PAD;   Drug: Placebo
    Sponsor:   Pluristem Ltd.
    Recruiting

  • Condition:   Alzheimer's Disease
    Interventions:   Biological: Longeveron Mesenchymal Stem Cells;   Biological: Placebo
    Sponsor:   Longeveron LLC
    Recruiting

  • Condition:   Cystic Fibrosis
    Interventions:   Biological: Allo-hMSCs;   Biological: Placebo
    Sponsor:   Joshua M Hare
    Not yet recruiting